Published in Dis Colon Rectum on June 01, 1986
Surveillance guidelines after removal of colorectal adenomatous polyps. Gut (2002) 2.71
Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut (2007) 1.79
Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years. Gut (1996) 1.50
Clinicopathological features of colon polyps from African-Americans. Dig Dis Sci (2010) 1.06
CT colonography with reduced bowel preparation after incomplete colonoscopy in the elderly. Eur Radiol (2008) 0.89
Management of subcentimetric polyps detected by CT colonography. Nat Rev Gastroenterol Hepatol (2012) 0.77
Nonsteroidal anti-inflammatory drugs for the prevention of colon cancer. CMAJ (1993) 0.76
Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance? Int J Technol Assess Health Care (2009) 0.75
OX VITREOUS HUMOUR. 1.-THE RESIDUAL PROTEIN. Br J Ophthalmol (1948) 7.46
THE SYNTHESIS OF A POLYSACCHARIDE FROM GLUCOSE-1-PHOSPHATE IN MUSCLE EXTRACT. Science (1939) 7.02
Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J (1994) 5.70
Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology (1997) 4.59
Cloning and characterization of genes involved in production of mannose-resistant, neuraminidase-susceptible (X) fimbriae from a uropathogenic O6:K15:H31 Escherichia coli strain. Infect Immun (1985) 3.58
Structural relationship of Salmonella O and R antigens. Ann N Y Acad Sci (1966) 3.54
Intestinal colonization and virulence of Salmonella in mice. Infect Immun (1978) 3.44
Immunochemistry of R lipopolysaccharides of Escherichia coli. Different core regions in the lipopolysaccharides of O group 8. Eur J Biochem (1969) 2.89
The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J Biol Chem (1999) 2.78
Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol (1993) 2.73
Activities, events and outcomes in ambulatory patient care. N Engl J Med (1969) 2.63
GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure. Mol Microbiol (2000) 2.56
Immunochemical studies on core lipopolysaccharides of Enterobacteriaceae of different genera. Eur J Biochem (1970) 2.29
Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infect Immun (1999) 2.26
Immunochemistry of R lipopolysaccharides of Escherichia coli. Studies on R mutants with an incomplete core, derived from E. coli O8:K27. Eur J Biochem (1970) 2.18
Escherichia coli adhesion to Saccharomyces cerevisiae and mammalian cells: role of piliation and surface hydrophobicity. Infect Immun (1981) 2.09
[Is ulcer disease an infectious disease?]. Dtsch Med Wochenschr (1994) 2.04
Chemistry and biology of the enterobacterial common antigen (ECA). Curr Top Microbiol Immunol (1979) 1.99
The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes Relat Metab Disord (2000) 1.99
One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol (1995) 1.93
Characterization of pili associated with Escherichia coli O18ac. Infect Immun (1980) 1.80
Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein. Infect Immun (2000) 1.78
Pseudomonas aeruginosa exoenzyme S ADP-ribosylates Ras at multiple sites. J Biol Chem (1998) 1.73
The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology (1993) 1.69
Interaction of small dermatan sulfate proteoglycan from fibroblasts with fibronectin. J Cell Biol (1987) 1.68
Rho GTPases as targets of bacterial protein toxins. Biol Chem (2000) 1.68
Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology (1996) 1.67
Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release. J Clin Invest (1990) 1.64
Cement leakage during vertebroplasty: an underestimated problem? Eur Spine J (2005) 1.64
On a bacteriophage T3 and T4 receptor region within the cell wall lipopolysaccharide of Escherichia coli B. J Mol Biol (1976) 1.57
Application of the Woman Abuse Screening Tool (WAST) and WAST-short in the family practice setting. J Fam Pract (2000) 1.56
Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. J Am Coll Cardiol (2001) 1.55
Small-angle neutron scattering study of lateral phase separation in dimyristoylphosphatidylcholine-cholesterol mixed membranes. Biochemistry (1985) 1.51
Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut (1994) 1.49
Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients. Am J Gastroenterol (1997) 1.48
Bacterial protein toxins targeting rho GTPases. FEMS Microbiol Lett (2000) 1.46
Tunneling anisotropic magnetoresistance: a spin-valve-like tunnel magnetoresistance using a single magnetic layer. Phys Rev Lett (2004) 1.45
Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection. Am J Gastroenterol (1995) 1.43
[Hemagglutinins against a common enterobacteriaceae antigen in E. coli R1-antisera]. Zentralbl Bakteriol Orig (1971) 1.42
Strong optical activity from twisted-cross photonic metamaterials. Opt Lett (2009) 1.39
Effect of medial displacement calcaneal osteotomy on ankle kinematics in a cadaver model. Foot Ankle Int (1998) 1.39
[The modified 13C-urea breath test in the diagnosis of Helicobacter pylori colonization of the gastric mucosa]. Dtsch Med Wochenschr (1994) 1.39
THE EFFECT OF NUCLEOPHOSPHATASE ON "NATIVE" AND DEPOLYMERIZED THYMONUCLEIC ACID. Science (1938) 1.39
[Helicobacter pylori: from harmless commensal to clinically significant disease factor]. Dtsch Med Wochenschr (1992) 1.38
[Bleeding peptic ulcers--how can recurrent bleeding be prevented?]. Leber Magen Darm (1995) 1.37
Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci U S A (1987) 1.36
The impact of body build on the relationship between body mass index and percent body fat. Int J Obes Relat Metab Disord (1999) 1.35
Immunogenicity of the common enterobacterial antigen produced by smooth and rough strains. Infect Immun (1972) 1.35
Interleukin-3 is a differentiation factor for human basophils. Blood (1989) 1.34
Genetic transfer of Salmonella O antigens to Escherichia coli O8. J Gen Microbiol (1976) 1.33
Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol (1994) 1.33
Presence of rfe genes in Escherichia coli: their participation in biosynthesis of O antigen and enterobacterial common antigen. J Bacteriol (1976) 1.32
SOME OBSERVATIONS ON THE EFFECT OF INJECTED CYTOCHROME C IN ANIMALS. J Clin Invest (1945) 1.31
Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut (1995) 1.30
Circular dichroism of planar chiral magnetic metamaterials. Opt Lett (2007) 1.29
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion (1994) 1.29
Alternative pathway for the activation of complement in human serum. Formation and composition of the complex with cobra venom factor that cleaves the third component of complement. Hoppe Seylers Z Physiol Chem (1974) 1.29
[Qualitative and semiquantitative invasive and noninvasive diagnosis of Helicobacter pylori colonization of gastric mucosa]. Z Gastroenterol (1993) 1.26
Isolation, crystallization, crystal structure analysis and refinement of B-phycoerythrin from the red alga Porphyridium sordidum at 2.2 A resolution. J Mol Biol (1992) 1.26
[Investigations on the classification of salmonella R forms. 3. Classification of S. minnesota mutants by chemical agents]. Zentralbl Bakteriol Orig (1969) 1.25
Genetical studies on the lipopolysaccharide structure of Escherichia coli K12. J Gen Microbiol (1973) 1.25
Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success. Scand J Gastroenterol (1994) 1.22
Enterobacterial common antigen in rfb deletion mutants of Salmonella typhimurium. J Bacteriol (1976) 1.22
Genetic and immunochemical studies on Escherichia coli O14:K7:H-. Eur J Biochem (1974) 1.21
A new function of the activated third component of complement: binding to C5, an essential step for C5 activation. Immunology (1978) 1.20
Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation (2000) 1.20
Complement activation by the properdin system: formation of a stoichiometric. C3 cleaving complex of properdin factor B with C36. Immunochemistry (1977) 1.19
Immunochemical studies of polysaccharide surface antigens of Escherichia coli 0100:K?(B):H2. Eur J Biochem (1970) 1.19
Negative-index metamaterial at 780 nm wavelength. Opt Lett (2007) 1.18
Body fat measurement among Singaporean Chinese, Malays and Indians: a comparative study using a four-compartment model and different two-compartment models. Br J Nutr (2001) 1.18
Intestinal and serum antibody responses in mice after oral immunization with Salmonella, Escherichia coli, and Salmonella-Escherichia coli hybrid strains. Infect Immun (1979) 1.17
Activation of Rho GTPases by Escherichia coli cytotoxic necrotizing factor 1 increases intestinal permeability in Caco-2 cells. Infect Immun (1998) 1.17
Gastric dysrhythmias and delayed gastric emptying in patients with functional dyspepsia. Dig Dis Sci (1997) 1.16
Influence of decorin on fibroblast adhesion to fibronectin. Eur J Cell Biol (1991) 1.16
Acute colonic pseudo-obstruction (Ogilvie's syndrome). Presentation of 14 of our own cases and analysis of 1027 cases reported in the literature. Surg Endosc (1987) 1.16
The cell-wall lipopolysaccharide of Escherichia coli K-12. Structure and acceptor site for O-antigen and other substituents. Eur J Biochem (1976) 1.16
Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis. Ann Hematol (2002) 1.14
Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose. Z Immunitatsforsch Exp Klin Immunol (1975) 1.14
Twisted split-ring-resonator photonic metamaterial with huge optical activity. Opt Lett (2010) 1.13
One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection. Aliment Pharmacol Ther (1996) 1.12
A family with a presumptive C-F translocation in five generations. Ann Genet (1971) 1.12
Reduction in mortality from upper gastrointestinal haemorrhage. Med J Aust (1983) 1.12
[Differentiation of Salmonella R forms by means of antibiotics ant antibacterial dyes]. Zentralbl Bakteriol Orig (1970) 1.12
Small plants, large plants: the importance of plant size for the physiological ecology of vascular epiphytes. J Exp Bot (2001) 1.11
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. Aliment Pharmacol Ther (2002) 1.10
Bistability of vortex core dynamics in a single perpendicularly magnetized nanodisk. Phys Rev Lett (2009) 1.10
Identification of the region of rho involved in substrate recognition by Escherichia coli cytotoxic necrotizing factor 1 (CNF1). J Biol Chem (1999) 1.08
[Therapeutic experience in the management of hypertonic blood circulation regulation disorders using Inderal]. Wien Klin Wochenschr (1967) 1.08
Pesky trachoma suspect finally caught. Br J Ophthalmol (2004) 1.07
Recombinant Yersinia YopT leads to uncoupling of RhoA-effector interaction. Infect Immun (2001) 1.07
Biomechanical model of the human knee evaluated by neuromuscular stimulation. J Biomech (1996) 1.06
Long-term consequences of Helicobacter pylori eradication: clinical aspects. Scand J Gastroenterol Suppl (1996) 1.06
Frequency of idiopathic gastric stasis and intestinal transit disorders in essential dyspepsia. J Clin Gastroenterol (1989) 1.06
[Poisoning by diphenhydramine--forensic-toxicologic interpretation of analytic results ]. Z Rechtsmed (1982) 1.06
The Ras mutant D119N is both dominant negative and activated. Mol Cell Biol (1999) 1.05
Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. Chest (1989) 1.04
Biochemical basis of the immunogenicity of the common enterobacterial antigen. Infect Immun (1972) 1.04
[Studies of the typing of Salmonella R forms. I. Microbiological and serological studies of Salmonella minnesota mutants]. Zentralbl Bakteriol Orig (1969) 1.04
Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton. J Pharmacol Exp Ther (1997) 1.04